Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle cremophor EL

Cancer Research

Volumn 56, Issue 9, 1996, Pages 2112-2115

  Sparreboom, Alex ^a   Van Teilingen, Olaf ^a   Nooijen, Willem J ^a   Beijnen, Jos H ^b,c  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b SLOTERVAART HOSPITAL   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CREMOPHOR; DRUG VEHICLE; PACLITAXEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DISPOSITION; DRUG EFFECT; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLYCEROL; HUMANS; MICE; PACLITAXEL; SOLVENTS; VEHICLES;

EID: 0029921281     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Huizing, M. T., Sewberath Misser, V. H., Pieters, R. C., Ten Bokkel Huinink, W. W., Veenhof, C. H. N., Vermorken, J. B., Pinedo, H. M., and Beijnen, J. H. Taxanes. A new class of antitumor agents. Cancer Invest., 13: 381-404, 1995
2. Huizing, M. T., Keung, A C. F , Rosing, H. Van der Kuij, V , Ten Bokkel Huinink, W. W., Mandjes, I. M , Dubbelman, A. C., Pinedo, H. M., and Beijnen, J. H Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients. J. Clin. Oncol., 11: 2127-2135, 1993.
3. Sonnichsen, D. S., Hurwitz, C. A., Pratt, C. B., Shuster, J. J., and Relling, M. V. Saturable pharmacokinetics and paclitaxel pharmacodynamics in children with solid tumors. J. Clin. Oncol., 12: 532-538, 1994.
4. Gianni, L , Kearns, C M., Capri, G., Vigano, L., Locatelli, A., Bonadonna, G., Giani, A., and Egorin, M. J Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans. J Clin. Oncol., 13: 180-190, 1995.
5. Hurwitz, C. A., Relling, M. V., Weitman, S. D., Ravindranath, Y., Vietti, T. J., Strother, D. R., Ragab, A. H., and Pratt, C. B. Phase I trial of paclitaxel in children with refractory solid tumors: a Pediatric Oncology Group study. J. Clin. Oncol., 11: 2324-2329, 1994.
6. Schiller, J. H., Tutsch, K , Arzoomanian, R., Alberti, Feierabend, C., and Spriggs, D. Phase I trial of a 3 hour taxol infusion plus or minus granulocyte colony stimulating factor (G-CSF). Proc. Am Soc. Clin. Oncol., 12: 166, 1993.
7. Eiseman, J. L., Eddington, N. D., Leslie, L., McAuley, C., Sentz, D L., Zuhowsky, M., Kujiwa, J. M , Young, D , and Egorin, M. J. Plasma pharmacokinetics and tissue distribution of paclitaxel in CD2F1 mice. Cancer Chemother. Pharmacol., 34: 465-471, 1994.
8. Sparreboom, A., Van Tellingen, O , Nooijen, W. J., and Beijnen, J H. Tissue distribution, metabolism and excretion of paclitaxel in mice Anti-Cancer Drugs, 7: 70-86, 1996.
9. Sparreboom, A , Huizing, M. T., Boessen, J. J. B., Nooijen, W. J., Van Tellingen, O., and Beijnen, J. H. Isolation, purification, and biological activity of mono- and dihydroxylated paclitaxel metabolites from human feces. Cancer Chemother. Pharmacol., 36: 299-304, 1995.
10. Sparreboom, A., Van Tellingen, O., Nooijen, W. J., and Beijnen, J. H. Determination of paclitaxel and metabolites in mouse plasma, tissues, urine and faeces by semi-automated reversed-phase high-performance liquid chromatography. J. Chromatogr., 664. 383-391, 1995
11. Sparreboom, A., Van Tellingen, O., Huizing, M. T., Nooijen, W. J , and Beijnen, J. H. Determination of polyoxyethyleneglycerol triricinoleate 35 (Cremophor EL) by precolumn derivatization and reversed-phase high-performance liquid chromatography. J. Chromatogr., in press, 1996.
12. Proost, J H., and Meijer, D K F MW£HARM, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring. Comput. Biol. Med., 22: 155-160, 1992.
13. Woodcock, D. M., Jefferson, S. Linsenmeyer, M. E , Crowther, P. J., Chojnowski, M., Williams, B., and Bertoncello, I. Reversal of the multidrug resistance phenotype with Cremophor EL, a common vehicle for water-insoluble vitamins and drugs. Cancer Res., 50 4199-4203, 1990.
14. Schuurhuis, G. J., Broxterman, H. J , Pinedo, H. M., Van Heijningen, T H. M., Van Kalken, C. K., Vermorken, J B., Spoelstra, E. C., and Lankelma, J. The polyoxyethylene castor oil Cremophor EL modifies multidrug resistance. Br. J. Cancer, 62: 591-594, 1990
15. Friche, E., Jensen, P. B., Sehested, M., Demant, E. J. F., and Nissen, N N The solvents Cremophor EL and Tween 80 modulate daunorubicin resistance in the multidrug resistant Ehrlich ascites tumor. Cancer Commun., 90: 297-303, 1990.
16. Ross, D D., Wooten, P J , Tong, Y , Comblatt, B , Levy, C., Sridhara, R., Lee, E. J., and Schiffer, C. A. Synergistic reversal of multidrug-resistance phenotype in acute myeloid leukemia cells by cyclosporin A and Cremophor EL. Blood, 83: 1337-1347, 1994.
17. Kim, S. N. Preclinical toxicology and pharmacology of dimethytacetamide, with clinical notes Drug Metab. Rev., 19: 345-368, 1988.
18. Webster, L. K., Linsenmeyer, M. E., Millward, M. J., Morton, C., Bishop, J , and Woodcock, D M. Measurement of Cremophor EL following taxol: plasma levels sufficient to reverse drug exclusion mediated by the multidrug resistant phenotype. J. Natl. Cancer Inst., 85. 1685-1690, 1993
19. Leveque, D., Jehl, F. P-glycoprotein and pharmacokinetics. Anticancer Res., 15: 331-336, 1995.
20. Sykes, E., Woodburn, K., Decker, D., and Kessel, D. Effects of Cremophor EL on the distribution of taxol to serum lipoproteins. Br. J Cancer, 70: 401-404, 1994.
21. Woodburn, K., Chang, C. K., Lu, S., and Kessel, D. Biodistribution and PDT efficacy of a ketochlorin photosensitizer as a function of the delivery vehicle. Photochem. Photobiol., 60 154-159, 1994.
22. Kessel, D. Properties of Cremophor EL micelles probed by fluorescence. Photochem. Photobiol , 56: 447-451, 1992.